Shin Poong Pharm Co Ltd

Overview

Shin Poong Pharm Co Ltd (Shin Poong) is a pharmaceutical company. The company is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. It provides drugs such as anti-malaria, antibiotics, anti-hypertensive, antifungal and antiviral agents, atherosclerosis, hyperlipidaemia, and heart failure. Shin Poong offers cardiovascular, bone related diseases, API's, anti-biotic, propulsive, anti-ulcer, anti-arthritis, anti-spasmodic, respiratory, and anti-helminthic APIs, among others. The company also provides process development, process improvement, qualitative and quantitative analysis, formulation drug delivery systems, clinical and non-clinical research among others. It has its operations through its production facilities located in Gyeonggi-do, Ansan-si, Banweol, and Chungbuk-do, South Korea. Shin Poong is headquartered in Ansan-si, Gyeonggi-do, South Korea.
Key Stats
Address
7, Wonsi-ro, Danwon-gu, Danwon-gu, ANSAN, South Korea
Headquarters

South Korea

Contact

82 31 4916191

Website
shinpoong.co.kr
No of Employees

840

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

019170 [KOSE]

Revenue (2020)

$168 m

3.1% (2020 vs 2019)
Net Income (2020)

$4 m

-12.5% (2020 vs 2019)
Net Profit Margin

3 %

-10% (2020 vs 2019)
Market Cap *

$3,194 m

EPS *

$0.1

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Shin Poong Pharm Co LtdBoryung Pharmaceutical Co LtdIldong Pharmaceutical Co LtdBinex Co Ltd
Key Information
Headquarters South Korea South Korea South Korea South Korea
Headquarter City ANSAN SEOUL SEOUL BUSAN
Headquarter State/Province - - - -
No. of Employees 840 1,144 1,433 390
Entity Type Public Public Public Public

Products & Services

Shin Poong is a contract manufacturing of pharmaceutical products and services. The key products and services of the company include the following:

Products
  • Anti-Malaria
  • Anthelmintic
  • Antibiotics
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • Analytical Services
  • API Chemical
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
Brands
  • Clamoxin
  • Bactacin
  • Lynactam
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Contracts/Agreements In January, the company and Kiara Health entered into a partnership to distribute artesunate-pyronaridine fixed-dose…
2016 Financing Agreements In April, Shin Poong Pharm.Co., announced a private placement of 7,766,990 shares for US$34.5 million.
2014 Others In February, the company opened a new research institute in Kwan-yang dong.
2013 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2005 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
1962 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


General Medicines Co Ltd
Shin Poong Daewoo PharmCo Ltd
Tian Jin Shin Poong Pharm Co Ltd

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
21 Jan 2021 Pharmafrique (Kiara Health) Enters into Co-Marketing Agreement with Shin Poong Pharma Partnership Shin Poong Pharm Co Ltd; Kiara Health Pty Ltd
03 Oct 2018 Shin Poong Pharm Co Ltd Enters Phase II Clinical Trial Agreement with FHI Clinical Inc for (artesunate + pyronaridine) (GDCT0345447) Contract Service Agreement Shin Poong Pharm Co Ltd; Shin Poong Pharm Co Ltd FHI Clinical Inc; FHI Clinical Inc
06 Apr 2016 Shin Pooong Pharm to Raise USD34.5 Million in Private Placement of Shares Equity Offering Shin Poong Pharm Co Ltd
07 May 2013 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
29 Apr 2013 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
08 Jan 2013 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

97

Active Jobs

8

Posted

0

Closed

Job Trends

Latest Jobs

Job title Company Country
In the second half of 2021, the Gyeonggi branch of the Sales Headquarters MR new hires and careers Shin Poong Pharm Co Ltd India
In the second half of 2021, new MR recruitment at the Nambu 1 branch of the Sales Headquarters Shin Poong Pharm Co Ltd India
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar